Cartilage Oligomeric Matrix Protein as a Marker of Osteoarthritis

Journal of Rheumatology

Volumn 31, Issue SUPPL. 70, 2004, Pages 45-49

  Jordan, Joanne M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CALCIUM BINDING PROTEIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; GLYCOPROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; THROMBOSPONDIN; BIOLOGICAL MARKER; CARTILAGE MATRIX PROTEIN; SCLEROPROTEIN;

ANTIBODY SPECIFICITY; BONE RADIOGRAPHY; CONFERENCE PAPER; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TISSUE SPECIFICITY; AGED; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; OUTCOME ASSESSMENT; REVIEW;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 1942486454     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Neidhart M, Hauser N, Paulsson M, DiCesare PE, Michel BA, Hauselmann HJ. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 1997;36:1151-60.
2. Sharif M, Saxne T, Shepstone L, et al. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol 1995;34:306-10.
3. Petersson IF, Boegard T, Svensson B, Heinegard D, Saxne T. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol 1998;347:46-50.
4. Conrozier T, Saxne T, Fan CS, et al. Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Ann Rheum Dis 1998;57:527-32.
5. Murphy E, FitzGerald O, Saxne T, Bresnihan B. Increased serum cartilage oligomeric matrix protein levels and decreased patellar bone mineral density in patients with chondromalacia patellae. Ann Rheum Dis 2002;61:981-5.
6. Vilim V, Voburka Z, Vytasek R, et al. Monoclonal antibodies to human cartilage oligomeric matrix protein: epitope mapping and characterization of sandwich ELISA. Clin Chim Acta 2003;328:59-69.
7. Clark AG, Jordan JM, Vilim V, et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum 1999;42:2356-64.
8. Vilim V, Vytasek R, Olejarova M, et al. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis. Osteoarthritis Cartilage 2001;9:612-8.
9. Vilim V, Olegarova M, Machacek S, Gatterova J, Kraus VB, Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 2002;10:707-13.
10. Jordan JM, Luta G, Stable T, et al. Ethnic and gender differences in serum cartilage oligomeric matrix protein: The Johnston County Osteoarthritis Project. Arthritis Rheum 2003;48:675-81.
11. Dragomir AD, Kraus VB Renner JB, et al. Serum cartilage oligomeric matrix protein increases with signs and symptoms of knee and hip arthritis in the absence of radiographic knee and hip osteoarthritis: the Johnston County Osteoarthritis Project. Osteoarthritis Cartilage 2002;10:687-91.
12. Dragomir AD, Arab L, Luta G, et al. Current hormone replacement therapy (HRT) and symptomatic knee and hip osteoarthritis (OA) in postmenopausal African-American and Caucasian women [abstract]. Arthritis Rheum 2002;46 Suppl:S469.